Saba Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,240,593
| Closed | -$12.7M | – | 623 |
|
|
2023
Q2 | $12.7M | Sell |
1,240,593
-17,684
| -1% | -$181K | 0.33% | 56 |
|
|
2023
Q1 | $12.7M | Hold |
1,258,277
| – | – | 0.24% | 109 |
|
|
2022
Q4 | $12.6M | Hold |
1,258,277
| – | – | 0.17% | 176 |
|
|
2022
Q3 | $12.2M | Hold |
1,258,277
| – | – | 0.14% | 245 |
|
|
2022
Q2 | $12.2M | Buy |
1,258,277
+138,000
| +12% | +$1.34M | 0.14% | 229 |
|
|
2022
Q1 | $10.9M | Buy |
+1,120,277
| New | +$10.9M | 0.16% | 201 |
|